- Home
- LPTH vs NBY Comparison
LPTH vs NBY Comparison
Compare LPTH & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- NBY
- Stock Information
- Founded
- LPTH 1985
- NBY 2000
- Country
- LPTH United States
- NBY United States
- Employees
- LPTH N/A
- NBY N/A
- Industry
- LPTH Semiconductors
- NBY
- Sector
- LPTH Technology
- NBY
- Exchange
- LPTH Nasdaq
- NBY Nasdaq
- Market Cap
- LPTH 388.2M
- NBY 15.7M
- IPO Year
- LPTH 1996
- NBY 2007
- Fundamental
- Price
- LPTH $9.82
- NBY $1.07
- Analyst Decision
- LPTH Strong Buy
- NBY Strong Buy
- Analyst Count
- LPTH 3
- NBY 1
- Target Price
- LPTH $6.83
- NBY $0.85
- AVG Volume (30 Days)
- LPTH 2.2M
- NBY 725.4K
- Earning Date
- LPTH 11-06-2025
- NBY 11-06-2025
- Dividend Yield
- LPTH N/A
- NBY N/A
- EPS Growth
- LPTH N/A
- NBY N/A
- EPS
- LPTH N/A
- NBY 0.41
- Revenue
- LPTH $37,202,630.00
- NBY $9,781,000.00
- Revenue This Year
- LPTH $61.33
- NBY $23.91
- Revenue Next Year
- LPTH $22.75
- NBY $32.05
- P/E Ratio
- LPTH N/A
- NBY $2.89
- Revenue Growth
- LPTH 17.26
- NBY 113.47
- 52 Week Low
- LPTH $1.40
- NBY $0.46
- 52 Week High
- LPTH $10.59
- NBY $4.44
- Technical
- Relative Strength Index (RSI)
- LPTH 66.05
- NBY 41.23
- Support Level
- LPTH $7.90
- NBY $1.15
- Resistance Level
- LPTH $10.59
- NBY $1.38
- Average True Range (ATR)
- LPTH 1.07
- NBY 0.17
- MACD
- LPTH 0.10
- NBY -0.09
- Stochastic Oscillator
- LPTH 86.97
- NBY 3.00
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.